GKB Ophthalmics Ltd
Incorporated in 1981, GKB Ophthalmics Ltd is in the business of manufacture and sale of ophthalmic lenses made up of Glass and Plastic
- Market Cap ₹ 57.3 Cr.
- Current Price ₹ 114
- High / Low ₹ 128 / 74.1
- Stock P/E
- Book Value ₹ 51.1
- Dividend Yield 0.00 %
- ROCE -3.96 %
- ROE -10.2 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 90.8 to 64.2 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -5.82% over past five years.
- Company has a low return on equity of -6.67% over last 3 years.
- Promoter holding has decreased over last 3 years: -8.51%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
31.13 | 32.21 | 31.38 | 29.85 | 31.17 | 40.65 | 37.43 | 30.47 | 25.56 | 21.34 | 27.05 | 27.73 | 30.29 | |
26.33 | 30.75 | 25.58 | 30.63 | 33.61 | 41.05 | 38.41 | 31.52 | 26.29 | 21.63 | 27.44 | 28.82 | 31.67 | |
Operating Profit | 4.80 | 1.46 | 5.80 | -0.78 | -2.44 | -0.40 | -0.98 | -1.05 | -0.73 | -0.29 | -0.39 | -1.09 | -1.38 |
OPM % | 15.42% | 4.53% | 18.48% | -2.61% | -7.83% | -0.98% | -2.62% | -3.45% | -2.86% | -1.36% | -1.44% | -3.93% | -4.56% |
1.20 | 1.25 | 1.18 | 1.72 | 23.08 | 4.11 | 1.05 | 2.62 | 1.38 | 2.33 | 1.91 | 2.09 | 2.14 | |
Interest | 2.66 | 2.88 | 2.86 | 2.49 | 1.61 | 1.26 | 1.23 | 1.39 | 1.35 | 1.34 | 1.34 | 1.50 | 1.51 |
Depreciation | 0.83 | 1.15 | 1.18 | 1.48 | 1.42 | 1.34 | 1.58 | 3.43 | 3.47 | 2.99 | 2.49 | 2.54 | 3.50 |
Profit before tax | 2.51 | -1.32 | 2.94 | -3.03 | 17.61 | 1.11 | -2.74 | -3.25 | -4.17 | -2.29 | -2.31 | -3.04 | -4.25 |
Tax % | 31.87% | 9.85% | 71.77% | 25.41% | 22.43% | 31.53% | 6.20% | 14.77% | 0.00% | 7.86% | 0.00% | 5.26% | |
1.71 | -1.19 | 0.83 | -2.26 | 13.66 | 0.76 | -2.58 | -2.78 | -4.17 | -2.11 | -2.31 | -2.88 | -4.16 | |
EPS in Rs | 4.12 | -2.86 | 2.00 | -5.44 | 32.89 | 1.83 | -6.21 | -5.99 | -8.27 | -4.19 | -4.58 | -5.71 | -8.26 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -1% |
5 Years: | -6% |
3 Years: | 3% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -3% |
3 Years: | 9% |
TTM: | -176% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 5% |
3 Years: | 16% |
1 Year: | 8% |
Return on Equity | |
---|---|
10 Years: | -9% |
5 Years: | -9% |
3 Years: | -7% |
Last Year: | -10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.15 | 4.64 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
Reserves | 14.20 | 13.01 | 13.84 | 11.14 | 24.80 | 25.44 | 22.78 | 30.03 | 30.21 | 27.73 | 25.36 | 22.48 | 20.74 |
13.64 | 15.09 | 12.51 | 8.62 | 7.22 | 7.19 | 9.93 | 10.05 | 10.04 | 11.97 | 11.75 | 11.22 | 11.19 | |
17.41 | 19.75 | 20.67 | 24.79 | 11.36 | 10.22 | 8.57 | 10.45 | 11.40 | 12.13 | 11.74 | 10.41 | 12.21 | |
Total Liabilities | 49.40 | 52.00 | 51.17 | 48.70 | 47.53 | 47.00 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 49.18 |
11.69 | 12.67 | 13.61 | 11.72 | 12.49 | 16.43 | 16.98 | 24.29 | 24.83 | 22.28 | 21.27 | 17.28 | 16.66 | |
CWIP | 2.68 | 2.29 | 0.57 | 0.57 | 0.57 | 0.57 | 0.24 | 0.00 | 0.00 | 1.23 | 3.29 | 3.82 | 3.85 |
Investments | 4.27 | 4.23 | 5.53 | 5.53 | 10.45 | 3.77 | 0.66 | 0.32 | 3.21 | 12.22 | 11.90 | 11.90 | 11.90 |
30.76 | 32.81 | 31.46 | 30.88 | 24.02 | 26.23 | 27.55 | 30.56 | 28.65 | 21.14 | 17.43 | 16.15 | 16.77 | |
Total Assets | 49.40 | 52.00 | 51.17 | 48.70 | 47.53 | 47.00 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 49.18 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2.72 | 1.97 | 5.47 | 5.87 | -11.90 | -4.20 | -3.71 | 5.31 | 6.13 | 2.11 | 2.33 | -1.14 | |
-4.45 | -1.02 | -0.65 | 0.13 | 14.74 | 5.50 | 2.28 | -8.63 | -5.68 | -11.52 | -0.83 | 2.40 | |
1.73 | -0.95 | -4.82 | -6.00 | -2.81 | -1.29 | 1.41 | 9.21 | 3.31 | 0.61 | -1.50 | -2.03 | |
Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | -0.02 | 5.88 | 3.76 | -8.80 | 0.00 | -0.78 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 163.56 | 154.57 | 175.87 | 176.57 | 92.63 | 66.00 | 101.81 | 129.49 | 148.08 | 127.25 | 80.96 | 64.23 |
Inventory Days | 376.48 | 432.20 | 409.77 | 350.98 | 285.25 | 283.50 | 264.10 | 154.90 | 133.50 | 256.82 | 141.86 | 161.81 |
Days Payable | 202.72 | 208.29 | 232.25 | 362.47 | 119.63 | 106.91 | 84.89 | 171.32 | 222.98 | 251.31 | 158.86 | 139.11 |
Cash Conversion Cycle | 337.33 | 378.48 | 353.40 | 165.08 | 258.24 | 242.59 | 281.01 | 113.07 | 58.61 | 132.77 | 63.96 | 86.93 |
Working Capital Days | 146.91 | 139.72 | 128.88 | 65.66 | 152.00 | 144.02 | 190.74 | 112.60 | 86.54 | 101.26 | 51.14 | 72.26 |
ROCE % | 17.67% | 7.63% | 17.31% | -3.86% | -6.26% | -0.77% | -4.13% | -8.09% | -6.29% | 0.13% | -2.14% | -3.96% |
Documents
Announcements
- Compliance Certificate Under Regulation 40(9)& 40(10) Of SEBI (LODR) Regulation ,2015 For The Year Ended March 31, 2024. 18 Apr
-
Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144, Dated November 26, 2018.
11 Apr - GKB Ophthalmics Limited, is not a "Large Corporate", as defined in the said Circular and hence , the said Circular is not applicable to us. …
- Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015, For The Year Ended March 31, 2024. 8 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2024. Kindly acknowledge receipt of the same.
- Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015 30 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Profile:[1]
a) Single Vision: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck 1.56 DayNite, 1.56 DayNite FAST CHANGE, 1.50 Q-SHADE +, 1.50 SunSensor
b) Bifocal: 1.498 CR-39, 1.50 Blucheck, 1.56 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
c) Progressive: 1.498 CR-39, 1.50 Blucheck, 1.56 DayNite, 1.56 DayNite Fast Change
d) Aspheric: 1.498 CR-39